SM-Sino Technology Investment

SM-Sino Technology Investment is a venture capital firm focused on the healthcare sector. It invests in biotech companies from seed rounds to pre-IPO stages.

SM-Sino Technology Investment

SM-Sino Technology Investment is a venture capital firm focused on the healthcare sector. It invests in biotech companies from seed rounds to pre-IPO stages. The firm has made 2 investments, including a Series B investment in Oncocross on September 04, 2020.

Website

www.smsino.co.kr

linkedin.com/company/sm-sino-technology-investment

General information

Firm type

Private Equity

Year founded

2015

Location

Region

Asia

Country

South Korea

City

Seoul

Corporate office

11, Saechang-ro, Mapo-gu, Seoul, Republic of Korea

Sector focus

PharmaceuticalsHealthcare Services

Who founded SM-Sino Technology Investment?

The firm was founded by a group of doctors, entrepreneurs, and venture capitalists. It does not publicly name individual founders on its website or through other primary sources.

What is SM-Sino Technology Investment's investment focus?

The firm invests exclusively in the pharmaceuticals and healthcare sectors. Its stated expertise ranges from early-stage technologies and incubation through to pre-IPO rounds.

How does SM-Sino source its deals?

SM-Sino's website emphasizes a hands-on approach that identifies early-stage technologies and supports startups through incubation and acceleration. The founders' combined medical and entrepreneurial backgrounds imply a network-driven sourcing model within the South Korean healthcare ecosystem.

Does SM-Sino participate in fund commitments or only direct deals?

Based on its description as a venture capital firm that invests directly in startups from seed to pre-IPO, SM-Sino appears to make direct investments. It has not publicly disclosed any fund-of-funds or LP commitments.

Which sectors does SM-Sino explicitly avoid?

SM-Sino states a specific focus on pharmaceuticals and healthcare. There is no indication that it invests in sectors such as consumer technology, enterprise software, or industrial tech.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Jun 3, 2026. Continuous refresh with full update cycles at least every 30 days.